Why antidepressants can stop working after initially helping
Antidepressant use continues to rise. In England, 96 million antidepressant prescription items were dispensed to an estimated 9.1 million patients in 2025–2026. These medicines are prescribed for depression and other conditions, including anxiety and some forms of pain.
Antidepressants are increasingly prescribed in England, with an estimated 96 million items dispensed to patients in 2025-2026. These medications treat depression and related conditions like anxiety and certain types of pain. However, there is a potential issue where an antidepressant that initially helps may stop working after some time.
This phenomenon is known as antidepressant tachyphylaxis, which can also be referred to as a "poop-out" or "breakthrough depression." Tachyphylaxis is distinct from treatment-resistant depression, where someone doesn't improve after trying at least two antidepressants at suitable doses for a sufficient period.
The exact reasons why antidepressants may stop being effective are unclear. One hypothesis is that the brain gradually adapts to prolonged exposure to the medication. Antidepressants affect chemical messengers in the brain, including serotonin, which plays a role in mood and other functions. Research suggests that treatment with antidepressants can alter how cells respond to serotonin, potentially through changes in receptors on cells that receive chemical signals.
However, this research does not definitively establish why a previously effective treatment might stop being helpful.
Another possibility is that returning symptoms may be due to factors like missed doses, the development of another health issue, or a worsening of depression despite treatment. Other medications could also impact the effectiveness of antidepressants. The challenge lies in identifying the cause, as returning symptoms do not necessarily indicate that the body has developed tolerance to the medication. This uncertainty makes it difficult to measure the prevalence of tachyphylaxis.
Studies on tachyphylaxis have reported rates ranging from 9% to 57%, depending on the study's methodology and duration of follow-up. This wide range makes it unclear how likely any individual person is to experience this issue. Additionally, different studies use varying methods and may count people whose returning symptoms may have other explanations.
Researchers have also differed in how they define tachyphylaxis, with some focusing on the return of depression after initial improvement, while others examine specific symptom clusters like tiredness, reduced motivation, and difficulty thinking clearly.
The first step in addressing tachyphylaxis is for a doctor to review what has changed, including the patient's symptoms, medication adherence, side effects, and any difficulties obtaining prescriptions. They may also consider other health conditions and concurrent medications. If the treatment is no longer effective, options could include adjusting the dose, switching to a different antidepressant, or adding another medication. This requires discussing the possible benefits and risks with the prescriber.
However, increasing the dose is not always more effective and can lead to additional side effects. Researchers still lack clear answers about why antidepressants sometimes stop working for some individuals and how best to respond in those cases. Given the widespread use of these medications, there are significant gaps in the evidence.
Anyone experiencing a decrease in the effectiveness of their antidepressant should discuss the change with their doctor. Abruptly stopping the medication can cause withdrawal symptoms, which may mimic the return of depression and include dizziness, anxiety, and mood changes. Any changes to treatment should be planned with the prescriber.
Written by urgent.news from Medical Xpress's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.